News
Could safety scupper Ionis, Pfizer's cholesterol drug vupano...
Ionis has reported phase 2b trial data for its Pfizer-partnered antisense drug vupanorsen for cholesterol lowering that showed it met its main efficacy targets, but raised a few safety conc
